Mutant KRAS and GATA6 Stratify Survival in Patients Treated with Chemotherapy for Pancreatic Adenocarcinoma: A Prospective Cohort Study.
突变型 KRAS 和 GATA6 可对接受化疗治疗的胰腺腺癌患者的生存率进行分层：一项前瞻性队列研究
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17050896
Chun Jung Won, Lee Dong-Eun, Han Nayoung, Heo SooBeen, Kim Hyeji, Lee Mi Rim, Park Hyeong Min, Han Sung-Sik, Park Sang-Jae, Kim Tae Hyun, Lee Woo Jin, Kim Yun-Hee, Kong Sun-Young, Woo Sang Myung
